Serum glycated albumin-to-albumin ratio and mortality risk in cardiovascular-kidney-metabolic syndrome: Evidence from NHANES over 15 years.

AIMS: To evaluate the prognostic value of serum albumin (ALB), glycated albumin (GA), and the GA-to-ALB ratio (%GA) for survival outcomes in individuals with cardiovascular-kidney-metabolic (CKM) syndrome. MATERIALS AND METHODS: This study included 4…

Preview only. Read the full abstract at the source